Energenesis Biomedical CO.,LTD.

NT$29.60As of Sun 8 Nov 2026, 12:00 UTC
TWSE:6657Healthcare
Country Taiwan
PE (Fwd) •••
TSR 8Y CAGR (2.05%)
Div yield —
ROE (34.15%)
Biotechnology
Beta (5Y) 0.40
PE TTM —
TSR TTM (34.37%)
Mkt cap NT$2.602B
ROIC (22.14%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$33
11.45%
(59.85%)
Hold 0|9|12|5|11
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.36
0.35
0.37
0.38
14.65%
11.47%
6.88%
1.06%
RevenueNT$M
185.6
181.5
182.8
177.5
16.12%
14.73%
9.53%
0.41%
Peers (US$78.59M)
Cap (US$)
PE
78.36M
—
Capital
TTM
5Y
10Y
Leveragex
0.536
(0.299)
(0.302)
EBIT/Intx
1.230
0.221
0.208
Own earn%
77.63
128.59
91.91
Sh yield%
39.04
51.97
50.39
Owners
Insiders/Inst%
2.52
28.20
Short interest%
1.32
SBC / revenue%
3.82
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
12–17
$1 testx
0.0
Incr. ROIC%
2